<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00161577</url>
  </required_header>
  <id_info>
    <org_study_id>0903-886</org_study_id>
    <nct_id>NCT00161577</nct_id>
  </id_info>
  <brief_title>Use of Ketorolac in Management of Post-Operative Pain After Heart Surgery</brief_title>
  <official_title>Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Ketorolac in the Management of Post-Operative Pain After Heart Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Weill Medical College of Cornell University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the safety and efficacy of ketorolac for post-operative pain management
      after heart surgery. Ketorolac appears to provide enhanced pain relief while also decreasing
      the requirements for morphine during the (immediate) 24-hour post-operative period.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Current practice at this institution does not include routine use of ketorolac for
      post-operative pain management of patients undergoing cardiac surgery. The investigators
      hypothesize that using Ketorolac as an adjunct to IV morphine can positively impact patient
      outcomes and reduce the occurrence of possible side effects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2004</start_date>
  <completion_date type="Actual">June 2006</completion_date>
  <primary_completion_date type="Actual">June 2006</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total morphine administered</measure>
    <time_frame>24 hours post operatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Chest tube drainage</measure>
    <time_frame>24 hours post operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Assessments (NIF, VC)</measure>
    <time_frame>24 hours post operatively</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS Pain Scale</measure>
    <time_frame>24 hours post operatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Pain Management Following Cardiopulmonary Bypass Surgery</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Group A = Ketorolac</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketorolac</intervention_name>
    <description>Intravenous ketorolac every 6 hours for 24 hours</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Toradol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo Comparator</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females &gt; 18 years of age at the screening visit.

          -  Undergoing coronary artery bypass graft or single valve repair or replacement
             requiring cardiopulmonary bypass.

          -  American Society of Anesthesiology (ASA) Physical Class 3, or 4.

          -  Willing able to use a PCA Pump

          -  Willing to receive iv morphine for 24 hours post initial ketorolac dose to control
             pain.

          -  Capable of speaking and understanding English sufficiently to provide written informed
             consent and responses to pain assessment scales and neurological questionnaires.

        Exclusion Criteria:

          -  Allergy or sensitivity to nonsteroidal anti-inflammatory drugs

          -  History of gastrointestinal bleeding or peptic ulcer

          -  Serum creatinine = 2.0 mg/dl or rise in serum creatinine of = 0.5 mg/dl or 25% within
             the preceding 10 days if known with the exception of patients with Dialysis Dependent
             End Stage Renal Disease (ESRD).

          -  Hepatic dysfunction

          -  Patients with low cardiac output syndrome (cardiac index &lt; 2.0) after cardiopulmonary
             bypass or pre-op ejection fraction &lt; 30%

          -  Inability to operate PCA pump

          -  Cardiothoracic reoperations

          -  Bleeding disorder
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gergory Kerr, M.D., MBA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Weill Medical College of Cornell University, New York Presbyterian Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York Presbyterian Hospital, Weill Cornell Medical College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2005</study_first_submitted>
  <study_first_submitted_qc>September 11, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>May 12, 2009</last_update_submitted>
  <last_update_submitted_qc>May 12, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 13, 2009</last_update_posted>
  <responsible_party>
    <name_title>Gregory Kerr, MD</name_title>
    <organization>Weill Cornell Medical College</organization>
  </responsible_party>
  <keyword>Ketorolac</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Ketorolac Tromethamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

